• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

粪便微生物群移植失败的分类：一项观察性研究，探讨粪便微生物群移植失败的时间和特征。

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures.

机构信息

Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.

出版信息

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1832-1833. doi: 10.1016/j.cgh.2017.10.031. Epub 2017 Nov 16.

DOI:10.1016/j.cgh.2017.10.031
PMID:29104129
Abstract

Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI), with cure rates higher than 80%. FMT failure is defined as diarrhea and a positive stool laboratory test for C difficile at any point during the 8-week follow-up period after FMT..

摘要

粪便微生物群移植（FMT）是治疗复发性艰难梭菌感染（rCDI）的有效方法，治愈率高于 80%。FMT 失败的定义为在 FMT 后 8 周的随访期间的任何时间出现腹泻和粪便艰难梭菌实验室检测阳性。

相似文献

1
Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures.粪便微生物群移植失败的分类：一项观察性研究，探讨粪便微生物群移植失败的时间和特征。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1832-1833. doi: 10.1016/j.cgh.2017.10.031. Epub 2017 Nov 16.
2
Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.粪便微生物移植后无症状艰难梭菌携带率较低：一项前瞻性临床和粪便评估。
Clin Microbiol Infect. 2018 Jul;24(7):780.e1-780.e3. doi: 10.1016/j.cmi.2017.10.022. Epub 2017 Nov 11.
3
Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.衰老对粪菌移植供体粪便微生物群组成的影响及其对临床结局的影响。
Dig Dis Sci. 2017 Apr;62(4):1002-1008. doi: 10.1007/s10620-017-4449-6. Epub 2017 Feb 8.
4
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.完全微生物群植入对于粪便微生物群移植后复发性艰难梭菌感染的恢复并非必不可少。
mBio. 2016 Dec 20;7(6):e01965-16. doi: 10.1128/mBio.01965-16.
5
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
6
Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?在复发性或难治性艰难梭菌感染患者中，冷冻粪便微生物群移植与新鲜粪便微生物群移植的效果是否相同：一项荟萃分析？
Diagn Microbiol Infect Dis. 2017 Aug;88(4):322-329. doi: 10.1016/j.diagmicrobio.2017.05.007. Epub 2017 May 18.
7
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
8
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.预测包裹粪菌移植后艰难梭菌感染的复发。
Microbiome. 2018 Sep 18;6(1):166. doi: 10.1186/s40168-018-0549-6.
9
Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.粪便微生物群移植治疗复发性艰难梭菌感染：一项更新的随机对照试验荟萃分析。
PLoS One. 2019 Jan 23;14(1):e0210016. doi: 10.1371/journal.pone.0210016. eCollection 2019.
10
Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature.实体器官移植患者复发性艰难梭菌感染的粪便微生物群移植：机构经验及文献综述
Transpl Infect Dis. 2018 Dec;20(6):e12967. doi: 10.1111/tid.12967. Epub 2018 Jul 31.

引用本文的文献

1
Factors for Treatment Failure After Fecal Microbiota Transplantation in Infection.粪便微生物群移植治疗感染后治疗失败的因素
Microorganisms. 2024 Dec 9;12(12):2539. doi: 10.3390/microorganisms12122539.
2
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review.粪便微生物群移植（FMT）作为一种现代辅助疗法在各种疾病和障碍中的安全性和有效性：综合文献综述。
Front Immunol. 2024 Sep 26;15:1439176. doi: 10.3389/fimmu.2024.1439176. eCollection 2024.
3
Evaluation of the safety and efficacy of fecal microbiota transplantations in bottlenose dolphins (Tursiops truncatus) using metagenomic sequencing.
使用宏基因组测序评估瓶鼻海豚（Tursiops truncatus）粪便微生物群移植的安全性和有效性。
J Appl Microbiol. 2024 Feb 1;135(2). doi: 10.1093/jambio/lxae026.
4
-Cresol Sulfate Is a Sensitive Urinary Marker of Fecal Microbiota Transplantation and Antibiotics Treatments in Human Patients and Mouse Models.硫酸对甲酚是人类患者和小鼠模型中粪便微生物群移植和抗生素治疗的敏感尿液标志物。
Int J Mol Sci. 2023 Sep 27;24(19):14621. doi: 10.3390/ijms241914621.
5
Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile.鉴定与粪菌移植治疗复发性艰难梭菌患者早期定植相关的供体脆弱拟杆菌编码蛋白的基因。
Sci Rep. 2023 Aug 29;13(1):14112. doi: 10.1038/s41598-023-41128-y.
6
Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model.粪便微生物群移植供体和膳食纤维干预共同促进小鼠模型的肠道健康。
Front Immunol. 2022 Feb 3;13:842669. doi: 10.3389/fimmu.2022.842669. eCollection 2022.
7
Development of a rational framework for the therapeutic efficacy of fecal microbiota transplantation for calf diarrhea treatment.开发一种合理的框架，用于评估粪便微生物群移植治疗犊牛腹泻的治疗效果。
Microbiome. 2022 Feb 21;10(1):31. doi: 10.1186/s40168-021-01217-4.
8
Fecal Microbiota Transplantation for Severe or Fulminant Infection: Systematic Review and Meta-analysis.粪便微生物群移植治疗严重或暴发性感染：系统评价与荟萃分析。
J Can Assoc Gastroenterol. 2021 Jul 23;5(1):e1-e11. doi: 10.1093/jcag/gwab023. eCollection 2022 Feb.
9
Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy.粪便微生物移植治疗接受化疗的实体瘤患者艰难梭菌感染是安全的。
Dig Dis Sci. 2022 Jun;67(6):2503-2509. doi: 10.1007/s10620-021-07024-z. Epub 2021 Jun 4.
10
Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.艰难梭菌感染患者在接触复发危险因素后对粪便微生物群移植的反应持久性。
Clin Infect Dis. 2021 Oct 5;73(7):e1706-e1712. doi: 10.1093/cid/ciaa1457.